WuXi AppTec Co., Ltd. (603259.SS) stock analysis

In our weekly check, WuXi AppTec Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2.

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd. is a Healthcare company (Medical - Diagnostics & Research) based in China, listed on SHH as 603259.SS.

What our checks show for 603259.SS

Red flags

• Analysts expect the net margin to shrink by 7.5 points from today's 45.5%.
• The stock has fallen as much as 78% from a peak. Would you have held through that?

Warning signs

• The price swings a lot: 40.6% annual volatility. Expect large ups and downs.
• The stock is still below its previous peak.

Strengths

• Debt is low: 0.09x equity.
• Operating profit covers interest 122 times over.
• The net margin rose by 23.3 points over 5 years, to 45.5%.
• The gross margin is 53.2% and has risen by 17.1 points: pricing power is holding.
• Analysts expect revenue to grow about 20.5% a year over the next years.
• Earnings per share grew 45% a year over the last 3 years.

Similar companies

TMO · DHR · 2268.HK · NTRA

Questions

What grade does WuXi AppTec Co., Ltd. (603259.SS) have?

In our weekly check, WuXi AppTec Co., Ltd. is graded A (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 2, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 603259.SS stock?

This week's biggest flags for WuXi AppTec Co., Ltd.: Margins expected to shrink, Deep past fall, Very volatile. In total 4 of 25 checks show a warning or a red flag.

What does WuXi AppTec Co., Ltd. do?

WuXi AppTec Co., Ltd. is a Healthcare company (Medical - Diagnostics & Research) based in China, listed on SHH as 603259.SS.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis